Medical and Clinical Science.
Real-time data. Real-time answers.
“Rivia empowers biotech medics by making it easy to review safety data alongside dosing and efficacy. Clinical leaders gain the ability to monitor data quality and trial progress with confidence.”
Jos Houbiers
CMO Calypso Biotech
For Medical Teams & Clinical Scientists
Study Start – Eligibility and Screening
Evaluate inclusion/exclusion criteria disposition by site, patient status, or user-defined clinical groupings.
Assess protocol deviations and root-causes for potential protocol adjustments.
Track and validate baseline data, such as biomarkers and disease activity, to confirm patient suitability and enhance PI collaboration.
Medical Monitoring
Transition from pooled overviews to patient-level data to evaluate signals and subgroup trends.
Correlate biomarkers, lab results, and clinical data to assess treatment impact and disease progression.
Monitor patient compliance by comparing visit schedules, IMP exposure adherence, and other recorded data.
Access real-time data updates to ensure compliance and maintain study quality.
Endpoint and Response Evaluation
Analyze treatment responses early by comparing clinical endpoints over time, as changes from baseline or multiples (e.g., iRECIST change from smallest, LFT as max ULN multiples) at population-level or by subgroup
Refine hypotheses by correlating clinical endpoints with baseline biomarkers, medical history, concomitant medications, and disease activity.
Key Advantages
Control and Clarity
View trial data from every necessary perspective for rapid, confident decisions.
Faster Decision-Making
Self-service analytics reduced dependency and streamlined reviews.
Adaptive Trial Design
Confident decisions to support flexible protocol adjustments.
Enhanced Collaboration
Up-to-date data foster clear, timely communication across teams.